QFW
REGN icon

QTR Family Wealth’s Regeneron Pharmaceuticals REGN Stock Holding History

QTR Family Wealth’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$358K Sell
574
-40
-7% -$27.2K 0.12% 179
2026
Q1 		$464K Buy
614
+64
+12% +$49K 0.19% 128
2025
Q4 		$415K Buy
550
+147
+36% +$99.8K 0.18% 127
2025
Q3 		$227K Buy
+403
New +$228K 0.11% 220

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

QTR Family Wealth's REGN Position: Q2 2026 in Review

QTR Family Wealth reduced its Regeneron Pharmaceuticals (REGN) stake by 6.5% in Q2 2026, selling an estimated $27.2K and leaving 574 shares worth $358K. The position accounts for 0.12% of the portfolio, ranked #179.

QTR Family Wealth first reported a position in REGN in Q3 2025 and has held it in 4 quarters since. The position peaked at $464K in Q1 2026. 1,340 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • QTR Family Wealth held 574 shares of Regeneron Pharmaceuticals worth $358K as of Q2 2026.
  • QTR Family Wealth sold 40 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $27.2K.
  • Regeneron Pharmaceuticals made up 0.12% of QTR Family Wealth's portfolio in Q2 2026, its #179 holding.
  • QTR Family Wealth first reported a position in Regeneron Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • QTR Family Wealth's Regeneron Pharmaceuticals position peaked at $464K in Q1 2026.
  • 1,340 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on QTR Family Wealth's 13F filing for Q2 2026, filed 27 Jul 2026.